RYCEF
Next report

Feb 25 2027in 140 days

EPS estimate

$0.28

Revenue estimate

$16.72B

EPS beats

9 of last 12

EPS surprise

2021: 238.4%2022: -296.8%2022: -333.4%2023: 233.8%2023: 261.0%2024: 75.4%2024: 53.6%2025: 0.25%2025: 63.2%2026: 0.32%2026: 24.5%
Mar 11 2021Jul 30 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Jul 30 2026$0.24$0.29+24.5%$13.51B$14.95B+10.6%
Feb 26 2026$0.19$0.19+0.3%$14.60B$14.82B+1.5%
Jul 31 2025$0.13$0.22+63.2%$12.18B$12.43B+2.1%
Feb 27 2025$0.12$0.12+0.2%$11.07B$11.09B+0.2%
Aug 1 2024$0.07$0.11+53.6%$10.03B$10.34B+3.2%
Feb 22 2024$0.06$0.11+75.4%$10.58B$10.77B+1.8%
Aug 3 2023$0.02$0.06+261.0%$7.78B$8.82B+13.3%
Feb 23 2023$0.02$0.05+233.8%$7.55B$8.93B+18.3%
Aug 4 2022($0.01)($0.03)-333.4%$6.62B$6.46B-2.4%
Feb 24 2022$0.01($0.02)-296.8%$8.67B$7.73B-10.8%
Aug 5 2021($0.02)$0.02+238.4%$7.53B$7.22B-4.0%
Mar 11 2021($0.01)($0.10)-712.2%$7.42B$8.48B+14.3%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+11.60%
EPS+16.06%
FY2028
Rev+11.43%
EPS+17.65%
FY2029
Rev+10.53%
EPS+13.78%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$23.33B$26.04B$29.01B$32.07B$34.86B
Low$22.27B$24.12B$27.26B$30.13B$32.76B
High$24.23B$27.54B$30.43B$33.63B$36.56B
EBITDA Avg$6.34B$7.17B$8.24B$9.25B$11.20B
Low$5.95B$6.72B$7.71B$8.64B$10.45B
High$6.65B$7.53B$8.67B$9.73B$11.81B
EBIT Avg$5.41B$6.21B$7.23B$8.16B$10.04B
Low$5.03B$5.76B$6.70B$7.56B$9.28B
High$5.73B$6.58B$7.66B$8.65B$10.64B
Net Income Avg$3.65B$4.24B$4.99B$5.67B$7.05B
Low$3.37B$3.91B$4.59B$5.23B$6.50B
High$3.88B$4.51B$5.30B$6.03B$7.50B
EPS Avg$0.43$0.50$0.59$0.67$0.83
Low$0.40$0.46$0.54$0.62$0.77
High$0.46$0.53$0.63$0.71$0.89
Analysts (Rev / EPS)19 / 419 / 48 / 59 / 415 / 4
AI Earnings SummaryQ4 2025
Checking for summary...

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.